IGF1 and Alzheimer disease: For example, aging (the main risk factor for AD) is associated with low serum levels of IGF-1 (Piriz et al., 2011), and type 2 diabetes is associated with peripheral hyperinsulinemia and low brain insulin levels that could result in reduced Aβ clearance (Giuffrida et al., 2012).